Asthma management guidelines: Updates, advances, and new options

Journal of Managed Care Pharmacy

Volumn 13, Issue 6 SUPPL. D, 2007, Pages

  Navarro, Robert P ^a   Schaecher, Kenneth L ^b   Rice, Gary K ^c  

^a NavarroPHARMA   (United States)

^b SelectHealth   (United States)

^c Kelsey Seybold Clinic   (United States)

Author keywords

Asthma; Asthma control; Guidelines; Managed care; Management

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL; PLACEBO; SALBUTAMOL; THEOPHYLLINE;

ASTHMA; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; PATIENT CARE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; MANAGED CARE PROGRAMS; PATIENT EDUCATION; PRACTICE GUIDELINES; PRIMARY PREVENTION; UNITED STATES;

EID: 35348935638     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Trends in asthma morbidity and mortality. American Lung Association, Epidemiologic and Statistics Unit; May 2005.
2. Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps BE. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62:126-33.
3. Mintz M. Asthma update: part I. Diagnosis, monitoring, and prevention of disease progression. Am Fam Physician. 2004;70:893-98.
4. Mathur SK, Busse WW. Asthma: diagnosis and management. Med Clin North Am. 2006;90:39-60.
5. Children & Asthma in America Web site. Available at: http://www.asthmainamerica.com/children_index.html. Accessed May 7, 2007.
6. Asthma in America Web site. Available at: http://www.asthmainamerica.com/ slides/children/08.html. Accessed May 3, 2007.
7. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403-06.
8. Guilbert TW, Morgan WJ, Zeiger RS, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol. 2004;114:1282-87.
9. National Asthma Education Prevention Program. NAEPP Expert Panel Report. Guidelines for the diagnosis and management of asthma - update on selected topics. 2002. NIH publication no. 97-4051. Available at: http://www.nhlbi.nih. gov/guidelines/asthma/index.htm. Accessed January 2, 2007.
10. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992;90:32-42.
11. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med. 2000;343:1054-63.
12. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354:1985-97.
13. Joint Task Force on Practice Parameters, American Immunology; American College of Allergy, Asthma and Immunology; and Joint Council of Allergy, Asthma and Immunology. Attaining optimal asthma control: a practice parameter. J Allergy Clin Immunol. 2005;116:S3-11.
14. Chipps BE, Spahn JD. What are the determinates of asthma control? J Asthma. 2006;43:567-72.
15. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59-65.
16. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997;156:787-93.
17. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? the gaining optimal asthma control study. Am J Respir Crit Care Med. 2004;170:836-44.
18. Highlights of the American Academy of Allergy, Asthma & Immunology 2007 Annual Meeting. New data from AAAAI 2007: An expert interview with Harold Nelson, MD. Available at http://www.medscape.com/viewprogram/6962. Accessed on May 7, 2007.
19. National Asthma Education Prevention Program. NAEPP Expert Panel Report Guidelines for the diagnosis and management of asthma (EPR-3). Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed January 2, 2007.
20. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) and ADVAIR DISKUS 250/50 [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2006